Diversity of the patients we serve is no secret at Montefiore in the Bronx, where I practice. You see it in their faces, clothing, languages, and accents. The people present an extraordinary array of ancestries, making the borough a microcosm of the world. As a healthcare provider, you may wonder about your treatments; maybe one Read more
Research
Editors’ Note: Susan Band Horwitz, Ph.D., was named a recipient of the 2019 Canada Gairdner International Awards for her pioneering research into Taxol, establishing the mechanism of action of the blockbuster chemotherapy drug, which has been used to treat cancers of the ovary, breast, and lung. Read the related news release and watch the video about Dr Read more
Late last year the New York Times reported that Dr. José Baselga, the chief medical officer of Memorial Sloan Kettering Cancer Center, had resigned for failing to disclose his conflicts of interest at professional meetings and in scientific and medical journals. The Times report says that Dr. Baselga—who also served as physician-in-chief at the center—“had Read more
Editors’ Note: The following blog post originally appeared on Oxford University Press’s Academic Insights for the Thinking World blog. Exactly who are we anyway? Over the last generation, population genetics has emerged as a science that has made the discovery of human origins, relatedness, and diversity knowable in a way that is simply not possible from studying texts Read more
Whether its faculty members are training medical and graduate students or designing new drugs, Einstein focuses on patient care. The latest edition of Einstein magazine illustrates our mission through a pair of education and research articles. Life-saving science Improved patient care can emerge directly from Einstein’s basic science labs, as we learn from the story Read more
Editors’ Note: 2018 marks the 10-year anniversary of Einstein’s Gottesman Institute for Stem Cell Research and Regenerative Medicine. We sat down with the director, Paul Frenette, M.D., to discuss recent advances in the field, his own research projects and his expectations for the coming decade. The Gottesman Institute for Stem Cell Research and Regenerative Medicine Read more
